---
title: "Influenza and Coronavirus: Comparative Evolution, Epidemiology, Antivirals, and Vaccines"
id: "pubmed-43058094"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43058094"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43058094/"
doi: "10.1038/s41392-026-03078-5"
published_at: "2026-11-20T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Influenza and Coronavirus: Comparative Evolution, Epidemiology, Antivirals, and Vaccines
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43058094
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43058094/)
- **DOI:** [10.1038/s41392-026-03078-5](https://doi.org/10.1038%2Fs41392-026-03078-5)
- **Published At:** 2026-11-20T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The review compared **influenza** viruses and **coronavirus** biology, noting both are enveloped, single-stranded RNA viruses but differ in genome architecture and mechanisms of genetic change. - Influenza’s segmented genome permits antigenic shift and reassortment; the authors reported coronaviruses use recombination, mutation accumulation, and insertions to cross species and escape immunity. - Transmission drivers overlap: wildlife reservoirs, intermediate hosts, live animal markets, intensive agriculture, and global travel contributed to human spillover events and pandemic propagation. - Antiviral development pathways diverged historically: M2 and neuraminidase inhibitors targeted influenza; polymerase and protease inhibitors have been emphasized for coronaviruses, while drug resistance remains a persistent problem. - Vaccine modalities reviewed included inactivated, live-attenuated, recombinant protein, **mRNA**, and viral vector platforms; these platforms have been applied to both virus families with varied success. - The authors argued for platform-based preparedness: broad-spectrum antivirals, universal vaccines, and enhanced ecological surveillance to detect and mitigate future respiratory-virus emergence. - The review noted ongoing gaps: the need for broad-spectrum agents, universal vaccine candidates, and proactive surveillance strategies; specific clinical trial designs, dosing regimens, and regulatory timelines were not reported in the abstract.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43058094/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43058094%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43058094/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43058094/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43058094/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43058094/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43058094/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43058094/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43058094%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43058094%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43058094/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43058094/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43058094/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43058094/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43058094/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43058094/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43058094/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43058094/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43058094/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/43058094/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43058094/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43058094/#substances) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Substances Review Signal Transduct Target Ther Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Signal+Transduct+Target+Ther%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Signal+Transduct+Target+Ther%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43058094/) . 2026 Nov 20;11(1):502. doi: 10.1038/s41392-026-03078-5. # Influenza virus and coronavirus: evolution, epidemiology, antiviral drugs and vaccine development [Hanjun Zhao](https://pubmed.ncbi.nlm.nih.gov/?term=Zhao+H&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-1 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. hanjunzhao@fudan.edu.cn.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-2 "Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-3 "State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-4 "Pandemic Research Alliance Unit at The University of Hong Kong, The University of Hong Kong, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn."), [Ruiqing Sun](https://pubmed.ncbi.nlm.nih.gov/?term=Sun+R&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-equal-contrib-explanation "Contributed equally")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-5 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China."), [Jie Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+J&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-equal-contrib-explanation "Contributed equally")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-5 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China."), [Jonathan Daniel Ip](https://pubmed.ncbi.nlm.nih.gov/?term=Ip+JD&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-equal-contrib-explanation "Contributed equally")[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-6 "State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China."), [Feiyu Fu](https://pubmed.ncbi.nlm.nih.gov/?term=Fu+F&cauthor_id=43058094)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-5 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China."), [Xinling Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+X&cauthor_id=43058094)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-7 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. xinlingwang18@fudan.edu.cn."), [Shibo Jiang](https://pubmed.ncbi.nlm.nih.gov/?term=Jiang+S&cauthor_id=43058094)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#full-view-affiliation-8 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. shibojiang@fudan.edu.cn.") Affiliations Expand ### Affiliations * 1 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. hanjunzhao@fudan.edu.cn. * 2 Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn. * 3 State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn. * 4 Pandemic Research Alliance Unit at The University of Hong Kong, The University of Hong Kong, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn. * 5 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. * 6 State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. * 7 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. xinlingwang18@fudan.edu.cn. * 8 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. shibojiang@fudan.edu.cn. # Contributed equally. * PMID: **43058094** * DOI: [ 10.1038/s41392-026-03078-5 ](https://doi.org/10.1038/s41392-026-03078-5) Item in Clipboard Review # Influenza virus and coronavirus: evolution, epidemiology, antiviral drugs and vaccine development Hanjun Zhao et al. Signal Transduct Target Ther. 2026. Show details Display options Display options Format Abstract PubMed PMID Signal Transduct Target Ther Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Signal+Transduct+Target+Ther%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Signal+Transduct+Target+Ther%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43058094/) . 2026 Nov 20;11(1):502. doi: 10.1038/s41392-026-03078-5. ### Authors [Hanjun Zhao](https://pubmed.ncbi.nlm.nih.gov/?term=Zhao+H&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-1 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. hanjunzhao@fudan.edu.cn.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-2 "Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn.")[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-3 "State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn.")[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-4 "Pandemic Research Alliance Unit at The University of Hong Kong, The University of Hong Kong, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn."), [Ruiqing Sun](https://pubmed.ncbi.nlm.nih.gov/?term=Sun+R&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-equal-contrib-explanation "Contributed equally")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-5 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China."), [Jie Zhang](https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+J&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-equal-contrib-explanation "Contributed equally")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-5 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China."), [Jonathan Daniel Ip](https://pubmed.ncbi.nlm.nih.gov/?term=Ip+JD&cauthor_id=43058094)[#](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-equal-contrib-explanation "Contributed equally")[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-6 "State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China."), [Feiyu Fu](https://pubmed.ncbi.nlm.nih.gov/?term=Fu+F&cauthor_id=43058094)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-5 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China."), [Xinling Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+X&cauthor_id=43058094)[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-7 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. xinlingwang18@fudan.edu.cn."), [Shibo Jiang](https://pubmed.ncbi.nlm.nih.gov/?term=Jiang+S&cauthor_id=43058094)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/43058094/#short-view-affiliation-8 "Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. shibojiang@fudan.edu.cn.") ### Affiliations * 1 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. hanjunzhao@fudan.edu.cn. * 2 Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn. * 3 State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn. * 4 Pandemic Research Alliance Unit at The University of Hong Kong, The University of Hong Kong, Hong Kong, Hong Kong SAR, China. hanjunzhao@fudan.edu.cn. * 5 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. * 6 State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. * 7 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. xinlingwang18@fudan.edu.cn. * 8 Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Medical College, Fudan University, Shanghai, China. shibojiang@fudan.edu.cn. # Contributed equally. * PMID: **43058094** * DOI: [ 10.1038/s41392-026-03078-5 ](https://doi.org/10.1038/s41392-026-03078-5) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Influenza viruses and coronaviruses are enveloped, single-stranded RNA viruses that pose persistent and pandemic threats to global public health. Despite belonging to distinct viral families, they share remarkable parallels in modes of transmission, clinical manifestations, and socioeconomic impacts, yet diverge fundamentally in evolutionary mechanisms and epidemiological trajectories. This review compares the history, spread, treatments, and vaccines for these two types of viruses. Influenza viruses possess a segmented genome, which enables antigenic shift and reassortment. In contrast, coronaviruses have large, nonsegmented genomes and rely on recombination, mutation accumulation, and insertions to achieve host switching and immune evasion. Both spread to humans through wildlife (intermediate hosts), live animal markets, intensive agriculture, and global travel. Antiviral strategies have evolved from M2 and neuraminidase inhibitors (NAIs) for influenza to polymerase inhibitors and protease inhibitors for coronavirus, yet drug resistance remains a common challenge. Vaccine platforms, including inactivated, live-attenuated, recombinant, mRNA, and viral vector technologies, have been deployed against both viruses. This review concludes that integrated, platform-based preparedness, encompassing broad-spectrum antivirals, universal vaccines, and proactive ecological surveillance, is essential for building pandemic-resilient public health systems capable of responding to both influenza and coronavirus threats, as well as future emerging respiratory viruses. © 2026. The Author(s). [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Competing interests: The authors declare no competing interests. ## References 1. 1. Monto, A. S. & Fukuda, K. Lessons from influenza pandemics of the last 100 years. Clin. Infect. Dis. 70, 951–957 (2020). - [PubMed](https://pubmed.ncbi.nlm.nih.gov/31420670/) - [PMC](https://pmc.ncbi.nlm.nih.gov/articles/7314237/) - [DOI](https://doi.org/10.1093/cid/ciz803) 2. 1. Markov, P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21, 361–379 (2023). - [DOI](https://doi.org/10.1038/s41579-023-00878-2) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/37020110/) 3. 1. Lowen, A. C. Constraints, drivers, and implications of influenza A virus reassortment. Annu Rev. Virol. 4, 105–121 (2017). - [PubMed](https://pubmed.ncbi.nlm.nih.gov/28548881/) - [DOI](https://doi.org/10.1146/annurev-virology-101416-041726) 4. 1. Harrington, W. N., Kackos, C. M. & Webby, R. J. The evolution and future of influenza pandemic preparedness. Exp. Mol. Med. 5
## Related Clinical Research

- [Sex differences in antibody breadth and memory after seasonal H3N2 influenza vaccination](https://medichelpline.com/clinical-feed/medrxiv-14-broader-functional-and-memory-antibody-responses-in-adult-females-than-males-in.md)
- [Borrelia duttonii: agent of African tick‑borne relapsing fever](https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-0-borrelia-duttonii.md)
- [Donor-Derived Ehrlichia ewingii Infection After Pediatric Liver Transplant, US 2023](https://medichelpline.com/clinical-feed/cdc-emerging-infectious-diseases-journal-1-transplant-associated-ehrlichia-ewingii-infection-in-pediatric-liver-recipient.md)
- [US Influenza Activity 2025–26: Early A(H3N2) Peak, Two Waves, and Pediatric Burden](https://medichelpline.com/clinical-feed/medrxiv-4-influenza-activity-in-the-united-states-during-the-2025-26-influenza-season.md)
- [Canine TMPRSS4 in MDCK sublines enables trypsin-independent influenza A virus replication](https://medichelpline.com/clinical-feed/biorxiv-2-endogenous-serine-proteases-in-mdck-sublines-support-trypsin-independent.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.